Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Shortage of human intravenous immunoglobulin--reasons and possible solutions.

Literature DB >> 17342189

Shortage of human intravenous immunoglobulin--reasons and possible solutions.

Jagadeesh Bayry¹, Michel D Kazatchkine, Srini V Kaveri.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2007 PMID： 17342189 DOI： 10.1038/ncpneuro0429

Source DB: PubMed Journal: Nat Clin Pract Neurol ISSN： 1745-834X

Keyword Cloud
Cited

× No keyword cloud information.

27 in total

1. New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins.

Authors: Martin Stangel
Journal: Ther Adv Neurol Disord Date: 2008-09 Impact factor: 6.570

Review 2. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Authors: Vir-Singh Negi; Sriramulu Elluru; Sophie Sibéril; Stéphanie Graff-Dubois; Luc Mouthon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal: J Clin Immunol Date: 2007-03-11 Impact factor: 8.317

3. Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis.

Authors: Dilip K Challa; Uta Bussmeyer; Tarique Khan; Héctor P Montoyo; Pankaj Bansal; Raimund J Ober; E Sally Ward
Journal: MAbs Date: 2013-06-19 Impact factor: 5.857

4. Novel therapeutic strategies for multiple sclerosis: potential of intravenous immunoglobulin.

Authors: Jagadeesh Bayry; Sébastien Lacroix-Desmazes; Srini V Kaveri
Journal: Nat Rev Drug Discov Date: 2009-07 Impact factor: 84.694

Review 5. Emerging antibody products and Nicotiana manufacturing.

Authors: Kevin J Whaley; Andrew Hiatt; Larry Zeitlin
Journal: Hum Vaccin Date: 2011-03-01

6. sHLA-I Contamination, a novel mechanism to explain ex vivo/in vitro modulation of IL-10 synthesis and release in CD8(+) T lymphocytes and in neutrophils following intravenous immunoglobulin infusion.

Authors: Massimo Ghio; Paola Contini; Maurizio Setti; Gianluca Ubezio; Clemente Mazzei; Gino Tripodi
Journal: J Clin Immunol Date: 2010-02-02 Impact factor: 8.317

Shortage of human intravenous immunoglobulin--reasons and possible solutions.

1. New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins.

Review 2. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

3. Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis.

4. Novel therapeutic strategies for multiple sclerosis: potential of intravenous immunoglobulin.

Review 5. Emerging antibody products and Nicotiana manufacturing.

6. sHLA-I Contamination, a novel mechanism to explain ex vivo/in vitro modulation of IL-10 synthesis and release in CD8(+) T lymphocytes and in neutrophils following intravenous immunoglobulin infusion.

Review 7. Targeting FcRn for therapy: from live cell imaging to in vivo studies in mice.

Review 8. Targeting Abeta and tau in Alzheimer's disease, an early interim report.

9. Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury.

10. Optimization of immunoglobulin substitution therapy by a stochastic immune response model.